Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

colchicine/sarcoma

Link salvestatakse lõikelauale
ArtiklidKliinilistes uuringutesPatendid
Leht 1 alates 55 tulemused

Effects of cytochalasin B and colchicine on the motility and growth of Yoshida sarcoma cells in vitro.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The effects of cytochalasin B (CB) and colchicine on the motility and growth of cultured Yoshida sarcoma cells are studied by cinematographic methods. CB was found to reduce the average locomotory rate of motile Yoshida sarcoma cells and to enhance the frequency of non-motile cells. On the other

The binding of colchicine by sarcoma 180 cells.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

Studies on effects of colchicine derivatives upon Yoshida sarcoma cells.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

Studies on colchicine derivatives; toxicity in mice and effects on mouse sarcoma 180.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

Damage induced in sarcoma 37 with chemical agents. V. Derivatives of colchicine and isocolchicine.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

Phase II study of CI-980 (NSC 635370) in patients with previously treated advanced soft-tissue sarcomas.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Doxorubicin and ifosfamide are the two most active agents in the treatment of soft-tissue sarcomas. Patients whose tumors have failed these two drugs have very limited systemic therapy options. It is, therefore, important to identify newer drugs with activity against this disease. CI-980 is a

Requirement for cell division for initiation of transcription of Rous sarcoma virus RNA.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Stationary chicken embryo fibroblasts exposed to Rous sarcoma virus (RSV) did not synthesize virus RNA until after division of the infected cells. Initiation of RNA transcription after cell division resulted in transcription of the entire viral genome and was followed shortly thereafter by
The aim of this investigation was to analyze the resistance to doxorubicin and daunorubicin of murine sarcoma 180 cells grown in vitro (monolayer) and in vivo (ascites form). The colchicine-resistant CHO cells were used as controls. A multidrug-resistant phenotype was found in all investigated cell
Synchronized chicken embryo fibroblasts, prepared by addition of serum to stationary cells arrested in Go, were exposed to the Prague strain of Rous sarcoma virus. At different times during the cell cycle, high molecular weight DNA was prepared from infected cells and examined for the presence of

Independent expression of avian sarcoma virus in doubly infected chicken embryo fibroblasts.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Infection of a chicken cell with avian sarcoma virus requires division of the infected cell before synthesis of infectious progeny is initiated. This requirement for a cell division for the complete expression of avian sarcoma virus has been examined further with chicken embryo fibroblasts infected
Dunn osteosarcoma, transplanted successively from the original spontaneous murine osteosarcoma, was cultured for generations and serial changes of cultured cells were observed morphologically and also from the view points of chromosomes and cytokinetics. 1) In the early generations of subculture,
A noncloned subline of 3T3FL cells was developed that was resistant to the toxicity of the ansamycin alkaloid maytansine. Culture of 3T3FL cells with serially increasing concentrations of maytansine resulted in a cell line resistant to maytansine at concentrations 118-fold higher than concentrations
Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge